Latest filing published 08 Aug 2019 for Marinemax INC, €62k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Dean S. Woodman: trading record in brief
Dean S. Woodman has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Marinemax Inc, Sciclone Pharmaceuticals Inc and GoPro, Inc. The record holds 79 filings, for trades running from 30 December 2005 to 7 August 2019.
In open-market terms, that means 3 purchases worth €68k on one side and 6 sales worth €509k on the other. Taken together, the sales exceed the purchases by €440k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 58 share grants and 7 option exercises. Since January 2019: no purchases and 1 sale on the market.
A typical purchase (the median) is worth €22k.
On 8 August 2019 came the latest disclosure, an open-market sale for €132k in Marinemax Inc. The clock since the last published purchase (19 November 2007) now reads 6,929 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Dean S. Woodman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$7.0013.0% of flowCommon StockSEC:0001209191-19-045100:0
- 10,000 shares@ US$14.7627.3% of flowCommon StockSEC:0001209191-19-045100:1
- 456 shares@ US$16.441.4% of flowCommon StockSEC:0001209191-19-040332:0
- 391 shares@ US$19.161.4% of flowCommon StockSEC:0001209191-19-022458:0
- 409 shares@ US$18.311.3% of flowCommon StockSEC:0001209191-19-001009:0
- 5,000 shares0Common StockSEC:0001209191-18-059179:0
- 10,000 shares@ US$2.814.4% of flowCommon StockSEC:0001209191-18-057776:0
- 10,000 shares@ US$25.9741.0% of flowCommon StockSEC:0001209191-18-057776:1
- 294 shares@ US$21.251.0% of flowCommon StockSEC:0001209191-18-053239:0
- 329 shares@ US$18.951.0% of flowCommon StockSEC:0001209191-18-040654:0
- 321 shares@ US$19.450.6% of flowCommon StockSEC:0001209191-18-022921:0
- 330 shares@ US$18.900.6% of flowCommon StockSEC:0001209191-18-000919:0
- 2,500 shares@ US$12.463.3% of flowCommon StockSEC:0001209191-17-056146:0
- 2,500 shares@ US$17.004.5% of flowCommon StockSEC:0001209191-17-056146:1
- 377 shares@ US$16.550.7% of flowCommon StockSEC:0001209191-17-055316:0
- 2,500 shares@ US$15.504.1% of flowCommon StockSEC:0001209191-17-050414:0
- 2,500 shares@ US$16.004.2% of flowCommon StockSEC:0001209191-17-050414:1
- 3,000 shares@ US$14.564.6% of flowCommon StockSEC:0001209191-17-049945:0
- 3,000 shares@ US$15.004.7% of flowCommon StockSEC:0001209191-17-049945:1
- 319 shares@ US$19.550.7% of flowCommon StockSEC:0001209191-17-042809:0
- 288 shares@ US$21.650.7% of flowCommon StockSEC:0001209191-17-024828:0
- 322 shares@ US$19.350.7% of flowCommon StockSEC:0001209191-17-000380:0
- 771 shares0Common StockSEC:0001209191-16-154915:0
- 48,074 shares0Common StockSEC:0001209191-16-153991:0
- 5,000 shares@ US$17.109.8% of flowCommon StockSEC:0001209191-16-150270:0
25 of 77 declarations